Prof. Hui Zheng | Neurotoxicity | Best Innovation Award
Chief from National cancer center, China
Professor Hui Zheng is an accomplished academic and researcher affiliated with the Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, China. With a background in anesthesiology and perioperative care, his research emphasizes the intersection of neurodevelopment, pharmacology, and surgical outcomes. His most recent work explores the neuroprotective effects of Vitamin K2 in neonatal mice subjected to multiple surgical interventions with anesthesia and analgesia. This research represents a significant step forward in addressing long-term cognitive and motor deficits associated with early-life surgical exposure. Professor Zheng’s career is marked by his dedication to bridging clinical challenges with translational research. He has engaged in peer review activities for journals such as Brain & Development and serves on the editorial board of the Chinese Journal of Anesthesiology. His leadership in national scientific societies further highlights his professional recognition. Though the number of published articles is limited, the innovative scope of his work indicates strong potential for broader impact. Professor Zheng brings a blend of clinical expertise, academic rigor, and research curiosity to the field of anesthesiology and perioperative neuroscience.
Professional Profile
Education
Professor Hui Zheng holds an extensive academic background that spans both Chinese and international institutions. He earned his bachelor’s degree from Harbin Medical University in 1992, where he was first trained in foundational medical sciences. He went on to pursue a Master’s degree and later a Doctorate at the Beijing Tuberculosis & Chest Tumor Institute between 1998 and 2008. These graduate studies provided him with specialized knowledge in respiratory medicine and clinical research, helping to shape his later interest in anesthesia-related complications and critical care. To further enhance his expertise and gain international exposure, Professor Zheng undertook a post-doctoral fellowship at Massachusetts General Hospital, affiliated with Harvard Medical School, in 2011. This experience placed him in one of the world’s most prestigious research environments, where he gained valuable training in cutting-edge methodologies and global perspectives in translational medicine. His educational journey reflects a strong foundation in clinical medicine, research methodology, and interdisciplinary collaboration. Through this diverse and rigorous academic preparation, Professor Zheng developed the expertise necessary to lead impactful research projects focused on perioperative care and neurodevelopment, positioning him well within the global scientific community.
Professional Experience
Professor Hui Zheng is currently a Professor at the Center for National Cancer, Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, China. This role positions him at the forefront of cancer care and anesthesiology research in one of China’s leading medical institutions. His responsibilities encompass clinical practice, academic mentoring, and scientific research. Prior to this role, his career evolved through significant clinical and academic experiences, including specialized training in pulmonary and thoracic diseases at the Beijing Tuberculosis & Chest Tumor Institute. His clinical and scientific expertise was further enhanced through his post-doctoral appointment at Massachusetts General Hospital and Harvard Medical School, where he engaged in high-level research involving anesthetic techniques and postoperative outcomes. In addition to his institutional roles, Professor Zheng serves in various national scientific committees. He is Vice Chairman of the Cancer Anesthesia and Analgesia Committee under the China Anti-Cancer Association and the Society of Perioperative Infection Control under the Chinese Society of Cardiothoracic and Vascular Anesthesiology. These appointments reflect his active engagement in shaping national policies, guiding clinical protocols, and advancing academic collaborations. His professional trajectory demonstrates a commitment to enhancing both scientific knowledge and clinical outcomes in perioperative care.
Research Interest
Professor Hui Zheng’s primary research interests lie at the intersection of anesthesiology, neurodevelopment, and perioperative medicine. His most notable research focuses on the impact of repeated anesthesia and surgery during the neonatal stage on long-term cognitive and motor function. In particular, he explores nutritional and pharmacological interventions such as the use of Vitamin K2 as a potential neuroprotective agent. This work addresses a critical knowledge gap in pediatric anesthesiology and contributes to a growing body of evidence on how early-life medical interventions can influence neurodevelopmental outcomes. His research aligns with broader interests in perioperative neurotoxicity, postoperative cognitive dysfunction, and pain management strategies in vulnerable populations. Professor Zheng is particularly interested in translational applications that move laboratory findings into clinical protocols, aiming to improve patient outcomes across developmental stages. He also shows interest in surgical oncology and infection control within the context of anesthesia, suggesting a multidisciplinary approach. His involvement in national scientific committees further supports his commitment to evidence-based improvements in perioperative care. Overall, his research interests reflect a forward-looking agenda aimed at integrating basic science discoveries with real-world clinical challenges in anesthesiology and neuroprotection.
Research Skills
Professor Hui Zheng brings a diverse set of research skills to the field of anesthesiology and perioperative neurodevelopment. His experimental work with animal models, particularly murine studies involving repeated anesthesia and surgical interventions, demonstrates his proficiency in in vivo experimentation. He has utilized behavioral assays, neurocognitive testing, and histopathological analyses to assess long-term cognitive and motor outcomes, suggesting strong technical expertise in both behavioral neuroscience and pathology. His investigations also involve pharmacological interventions, such as the use of Vitamin K2, indicating a solid foundation in drug administration protocols and dosage optimization. Professor Zheng’s post-doctoral training at Massachusetts General Hospital likely provided him with advanced exposure to clinical research methodologies, including study design, data interpretation, and biostatistics. In his current role, he likely oversees collaborative research teams, contributing to research planning, data management, and publication processes. His editorial board membership and peer review activity reflect additional skills in scientific critique, literature evaluation, and academic publishing. Though his ORCID profile shows limited publicly listed outputs, the quality and depth of his known research suggest a strong competency in conducting and supervising both basic and translational scientific studies.
Awards and Honors
While Professor Hui Zheng holds several prestigious leadership positions within professional societies, there is currently no publicly available information detailing specific awards or honors in his academic profile. Despite this, his appointments as Vice Chairman of the Cancer Anesthesia and Analgesia Committee under the China Anti-Cancer Association and the Society of Perioperative Infection Control under the Chinese Society of Cardiothoracic and Vascular Anesthesiology serve as strong indicators of professional recognition. These roles are typically awarded to individuals with significant contributions to clinical excellence, academic research, and policy development. Additionally, his appointment to the editorial board of the Chinese Journal of Anesthesiology signals trust from the academic community and reflects recognition of his expertise in reviewing and curating scientific work. While formal awards such as innovation medals, national science honors, or institutional accolades are not listed, Professor Zheng’s current titles and roles suggest a high level of institutional respect and academic leadership. His career trajectory indicates that he may be in a strong position to receive such honors in the future as his research continues to evolve and attract attention within the scientific and medical communities.
Conclusion
Professor Hui Zheng is a promising figure in the field of anesthesiology, particularly in perioperative neuroprotection and pediatric anesthetic outcomes. His research on the neuroprotective role of Vitamin K2 in neonatal mice exposed to repeated anesthesia highlights both scientific creativity and clinical relevance. He holds notable academic and clinical positions, including his current professorship at the Cancer Hospital of the Chinese Academy of Medical Sciences. His international training at Harvard Medical School and Massachusetts General Hospital adds further depth to his global academic exposure. Professor Zheng is actively involved in national scientific societies and peer-reviewed publishing, which affirms his credibility and leadership in the field. While the quantity of published work and public honors appears limited at present, the quality and innovation embedded in his research indicate strong potential for future impact. His blend of clinical insight and experimental precision positions him well for future awards and broader recognition. For the Best Innovation Award in Research, he represents a candidate with clear intellectual rigor and translational promise, though a more extensive record of innovation-related achievements and research output would further strengthen his nomination.
Publications Top Notes
-
Title: Vitamin K2 mitigates cognitive and motor impairments induced by multiple surgery with anesthesia and analgesia in neonatal stage
-
Journal: Biochemical and Biophysical Research Communications
-
Publication Date: June 2025
-
Contributors: Yu Hou, Shuai Li, Qi Hou, Runjia Wang, Xiyuan Xu, Zhichao Li, Linhui Ma, Qidong Liu, Yuan Shen, Hui Zheng